RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
TFF Pharmaceuticals - Stock

TFF Pharmaceuticals Market capitalization 2024

TFF Pharmaceuticals Market capitalization

3.48 M USD

Ticker

TFFP

ISIN

US87241J1043

WKN

A2PQ7K

In 2024, TFF Pharmaceuticals's market cap stood at 3.48 M USD, a -83.04% increase from the 20.5 M USD market cap in the previous year.

The TFF Pharmaceuticals Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2026e5.88--
2025e0.31--
2024e0.44--
20230.73--
20220.5--
20210.09--
2020---
2019---
2018---
2017---
2016---

TFF Pharmaceuticals Aktienanalyse

What does TFF Pharmaceuticals do?

TFF Pharmaceuticals Inc is a biopharmaceutical company founded in 2018 and based in Austin, Texas. The company specializes in the development of inhalable drugs based on Thin Film Freezing technology. The history of TFF Pharmaceuticals began with the merger of two companies, Peloton Therapeutics and Infini Exploration. As a result of this fusion, the present-day TFF Pharmaceuticals was created. Since then, the company has experienced rapid growth and has become a leading provider of innovative inhalable medications. TFF Pharmaceuticals' business model includes the development and marketing of inhalable drugs based on patented Thin Film Freezing technology. This technology enables the production of medications in the form of nanoparticles that can be easily inhaled into the respiratory system. As a result, the drugs can directly reach the affected area of the lungs and have an immediate effect. TFF Pharmaceuticals' portfolio includes various areas such as oncology, respiratory diseases, infectious diseases, and rare diseases. The company is currently developing a variety of products in these areas, which have a significant market demand and can improve patients' quality of life. One example of a TFF Pharmaceuticals product is the inhalable medication Voriconazole-TFF. It is an innovative formulation of Voriconazole, an antifungal used for fungal infections. Voriconazole-TFF achieves a higher concentration in lung tissue and thus has a higher effectiveness than conventional Voriconazole products. The medication has been approved by the U.S. Food and Drug Administration (FDA) and is already on the market. Another example is the inhalable medication Tacrolimus-TFF, which is being developed for the treatment of lung transplant rejections. The Thin Film Freezing technology enables the production of Tacrolimus in nanoparticles that can directly reach the lungs and activate immunosuppression specifically there. TFF Pharmaceuticals closely collaborates with various partners to successfully market its products. These include pharmaceutical companies that take over the marketing of the products in different countries, as well as research institutes and medical facilities that work with TFF Pharmaceuticals to further develop its technology and products. Overall, TFF Pharmaceuticals is an innovative company specialized in the development of inhalable medications. With its patented Thin Film Freezing technology, the company has quickly made a name for itself and successfully brought its products to the market. TFF Pharmaceuticals' products have the potential to improve the lives of millions of patients worldwide, and the company will continue to play an important role in the pharmaceutical industry. TFF Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring TFF Pharmaceuticals's Market Capitalization

TFF Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of TFF Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

TFF Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in TFF Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about TFF Pharmaceuticals Stock

What is the current TFF Pharmaceuticals market capitalization?

The current market capitalization of TFF Pharmaceuticals is 3.48 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like TFF Pharmaceuticals.

How has the market capitalization of TFF Pharmaceuticals developed in recent years?

The market capitalization of TFF Pharmaceuticals has increased/decreased by -83.04% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of TFF Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of TFF Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of TFF Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does TFF Pharmaceuticals pay?

Over the past 12 months, TFF Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TFF Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of TFF Pharmaceuticals?

The current dividend yield of TFF Pharmaceuticals is .

When does TFF Pharmaceuticals pay dividends?

TFF Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TFF Pharmaceuticals?

TFF Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of TFF Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TFF Pharmaceuticals located?

TFF Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von TFF Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TFF Pharmaceuticals from 6/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2024.

When did TFF Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/16/2024.

What was the dividend of TFF Pharmaceuticals in the year 2023?

In the year 2023, TFF Pharmaceuticals distributed 0 USD as dividends.

In which currency does TFF Pharmaceuticals pay out the dividend?

The dividends of TFF Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TFF Pharmaceuticals

Our stock analysis for TFF Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TFF Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.